Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CBL-A2
- Development stage
- Unknown
- Lead developer
- Caliway Biopharmaceuticals
- Modality
- Small Molecules
- Administration
- Subcutaneous
01
Overview
CBL-A2 is an investigational drug evaluated as a comparator arm in randomized, placebo-controlled Phase 2b clinical trials for the reduction of subcutaneous abdominal fat. In these studies, CBL-A2 is administered via subcutaneous injection and compared to both placebo and another investigational agent, CBL-514. The primary indication under investigation is non-surgical localized fat reduction in adults with moderate or severe abdominal fat[2][5][7]. The specific mechanism of action, chemical structure, developer, and broader pharmacological details for CBL-A2 have not been disclosed in publicly available sources. It appears to be used primarily as a control or active comparator rather than as a lead therapeutic candidate. The developer is Caliway.
- Brand names
- Cystadane
- Other names
- trimethylglycineglycine betaine
Beyond the preview
Go deeper on CBL-A2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CBL-A2.